Sort by
Refine Your Search
-
translational environment of the UCL Institute of Neurology, the ARUK UDDI is uniquely placed to find novel targets, rapidly validate identified novel targets and mechanisms, establish screens and progress
-
translational environment of the UCL Institute of Neurology, the ARUK UDDI is uniquely placed to find novel targets, rapidly validate identified novel targets and mechanisms, establish screens and progress
-
The UCL Cancer Institute is the hub for cancer research at University College London (UCL), one of the world's leading universities (www.ucl.ac.uk/cancer ). We are looking for a talented and
-
We are seeking a collaborative and self-motivated computational post-doctoral fellow to work on cancer cachexia in a vibrant and highly collegiate environment. The candidate will be expected to make
-
About us The Radar Group within the Electronic and Electrical Engineering Department at UCL has a strong focus on practical applications of Radio Frequency (RF) sensing. Our research aims to advance
-
of UCL's London Bloomsbury Campus. LMCB scientists explore the dynamic control of cells and their environment during development, physiology and disease using a range of model systems and advanced molecular
-
support training and help foster a collaborative lab environment. Key Responsibilities These include but are not limited to: Designing experiments and research strategy in consultation with the PI Carrying
-
. The UCL GOS ICH, together with its clinical partner Great Ormond Street Hospital for Children, forms the largest concentration of children’s health research outside North America. The 2024-29 GOS ICH
-
a full job description please visit UCL’s online recruitment portal (https://www.ucl.ac.uk/work-at-ucl/search-ucl-jobs ) and search using vacancy reference B02-10144. To apply, please upload a current
-
environments will provide the successful candidate with opportunities to learn from a large network of talented professionals. Prof. Mariam Jamal-Hanjani is Principal Investigator of the TRACERx study at UCL